Literature DB >> 2417701

Metastatic phenotype of human prostate tumor cells in athymic nude mice: alteration by exposure to ethyl methanesulfonate and "reversion" by 5-azacytidine.

J L Ware, A P Lieberman, K S Webb.   

Abstract

The human prostate tumor subline 1-LN-PC-3-1A (1-LN) is reproducibly metastatic in adult athymic nude mice. Cells surviving a brief in vitro exposure to ethyl methanesulfonate (EMS) exhibited a profound decrease in capacity for experimental lung metastasis in nude mice. Thirty days after EMS treatment, 1 X 10(6) uncloned EMS-treated 1-LN cells (1-LN-EMS-10) were injected IV into groups of 6 to 8-week-old male athymic nude mice (BALB/cAnBOM). A median of 8.5 colonies/lung was observed among 20 1-LN-EMS-10-injected mice, which was significantly different from the median of 51 colonies/lung produced among 14 1-LN-injected mice (P = 0.0002). This altered phenotype remained stable during 150 days of continuous culture. However, the 1-LN-EMS-10 cells were tumorigenic in 10/10 nude mice injected SC. Single lung tumor colonies recovered from 1-LN-EMS-10-injected mice and reinjected IV into nude mice produced medians of 32-63 colonies/lung. The altered metastatic phenotype resulting from treatment of 1-LN with EMS was reversed by exposure to a noncytotoxic dose of 5-azacytidine, but unaffected by a second exposure to EMS. Collectively these data demonstrate that the metastatic phenotype of these human tumor cells in athymic nude mice can be heritably altered by in vitro exposure to EMS and 5-azacytidine. Analysis of the mechanisms underlying these phenotypic changes may provide insight into parts of the complex process of tumor cell evolution.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2417701     DOI: 10.1007/bf00199378

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  24 in total

1.  Induction of prolactin-deficient variants of GH3 rat pituitary tumor cells by ethyl methanesulfonate: reversion by 5-azacytidine, a DNA methylation inhibitor.

Authors:  R D Ivarie; J A Morris
Journal:  Proc Natl Acad Sci U S A       Date:  1982-05       Impact factor: 11.205

Review 2.  On a possible epigenetic mechanism(s) of tumor cell heterogeneity. The role of DNA methylation.

Authors:  P Frost; R S Kerbel
Journal:  Cancer Metastasis Rev       Date:  1983       Impact factor: 9.264

3.  Shifts in tumor cell phenotypes induced by signals from the microenvironment. Relevance for the immunobiology of cancer metastasis.

Authors:  V Schirrmacher
Journal:  Immunobiology       Date:  1980-07       Impact factor: 3.144

4.  In vitro synergism between hybrid immunotoxins and chemotherapeutic drugs: relevance to immunotherapy of prostate carcinoma.

Authors:  K S Webb; S N Liberman; J L Ware; P J Walther
Journal:  Cancer Immunol Immunother       Date:  1986       Impact factor: 6.968

5.  Spontaneous metastasis of cells of the human prostate carcinoma cell line PC-3 in athymic nude mice.

Authors:  J L Ware; D F Paulson; G H Mickey; K S Webb
Journal:  J Urol       Date:  1982-11       Impact factor: 7.450

6.  Synergistic effects of active specific immunotherapy and chemotherapy in guinea pigs with disseminated cancer.

Authors:  M E Key; J S Brandhorst; M G Hanna
Journal:  J Immunol       Date:  1983-06       Impact factor: 5.422

Review 7.  Possible epigenetic mechanisms of tumor progression: induction of high-frequency heritable but phenotypically unstable changes in the tumorigenic and metastatic properties of tumor cell populations by 5-azacytidine treatment.

Authors:  R S Kerbel; P Frost; R Liteplo; D A Carlow; B E Elliott
Journal:  J Cell Physiol Suppl       Date:  1984

8.  Influence of tumour size on human prostate tumour metastasis in athymic nude mice.

Authors:  J L Ware; E R DeLong
Journal:  Br J Cancer       Date:  1985-03       Impact factor: 7.640

9.  Growth control variant cell line having increased serum requirement and decreased response to platelet-derived growth factor: reversion by 5-azacytidine.

Authors:  D S Straus; D L Coppock
Journal:  J Cell Biol       Date:  1984-11       Impact factor: 10.539

10.  Immunogenic variants obtained by mutagenesis of mouse mastocytoma P815. II. T lymphocyte-mediated cytolysis.

Authors:  T Boon; J Van Snick; A Van Pel; C Uyttenhove; M Marchand
Journal:  J Exp Med       Date:  1980-11-01       Impact factor: 14.307

View more
  5 in total

1.  Induction of invasive and metastatic potential in mouse T-lymphoma cells (BW5147) by treatment with 5-azacytidine.

Authors:  G G Habets; R A van der Kammen; E H Scholtes; J G Collard
Journal:  Clin Exp Metastasis       Date:  1990 Nov-Dec       Impact factor: 5.150

Review 2.  Prostate cancer progression. Implications of histopathology.

Authors:  J L Ware
Journal:  Am J Pathol       Date:  1994-11       Impact factor: 4.307

Review 3.  Chemical xenogenization of experimental tumors.

Authors:  P Puccetti; L Romani; M C Fioretti
Journal:  Cancer Metastasis Rev       Date:  1987       Impact factor: 9.264

Review 4.  Growth factors and their receptors as determinants in the proliferation and metastasis of human prostate cancer.

Authors:  J L Ware
Journal:  Cancer Metastasis Rev       Date:  1993-09       Impact factor: 9.264

5.  Clonal analysis of the malignant properties of B16 melanoma cells treated with the DNA hypomethylating agent 5-azacytidine.

Authors:  D L Trainer; T Kline; G Hensler; R Greig; G Poste
Journal:  Clin Exp Metastasis       Date:  1988 May-Jun       Impact factor: 5.150

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.